My doctor prescribed a bone drug. What does it actually do?
Here's the point
Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.
Bone is constantly being broken down by cells called osteoclasts and rebuilt by cells called osteoblasts, a cycle called bone remodeling. Most osteoporosis drugs work by shifting the balance of this cycle in one of two directions. Antiresorptives — bisphosphonates like Fosamax, Actonel and Reclast, plus denosumab (Prolia) — slow down the osteoclasts, so bone removal falls behind bone formation. Anabolic agents — teriparatide, abaloparatide, and romosozumab — instead push osteoblasts to lay down new bone directly.
Bisphosphonates are the most commonly prescribed and most studied option, bound into bone itself, and they've shown meaningful reductions in fracture risk in large trials. Denosumab works differently: it blocks a signal called RANKL that tells bone-removing cells to mature. An important detail if you're on denosumab is that its effect doesn't linger in bone the way bisphosphonates do — stopping without a follow-up plan has been linked to rapid rebound bone loss, so any change should go through your physician.
Anabolic agents like teriparatide and romosozumab tend to produce bigger bone density gains and are usually reserved for higher-risk situations. They're used for a limited time, and the gains typically need to be protected afterward with an antiresorptive. It's also worth knowing that the number on your bone density scan isn't the whole story — architecture and the pace of bone turnover matter too, which is part of why your doctor looks at more than just that one figure.
None of this is a reason to start, stop, or change anything — that decision stays between you and your prescriber. What's useful is going in with specific questions: which family your drug is in, how long you're expected to stay on it, what the plan is afterward, and what should be monitored along the way.
Know these words
Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…
Anabolic bone agents are medications, like teriparatide, abaloparatide, and romosozumab, that stimulate the body to…
Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…
Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone…
Teriparatide (Forteo) is a daily injected medication that stimulates bone-building cells to form new bone, rather…
RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…
How sure is this?
Graded Established Science: Supported by broad scientific consensus and decades of research. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
The lessons behind this answer
More on medications and hormones
That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.
Read the full answer →Stopping Prolia (denosumab) isn't a neutral event. Because it doesn't build up in your bones the way bisphosphonates do, its protective effect wears off once doses stop. This can lead to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within months — so this is a decision to make with your prescriber, not on your own.
Read the full answer →Yes, it's possible — a number of common medications can affect bone, so it's a smart question to ask. This doesn't mean you should change anything on your own; it just means it's worth reviewing your full medication list with your prescriber to understand whether bone monitoring makes sense for you.
Read the full answer →Whether hormone therapy is right for your bones is a decision only you and your prescriber can make, based on your personal history — but it's worth knowing the evidence on hormones and bone is actually strong and has often been misrepresented, which is likely why your doctor is being careful. The caution usually traces back to one 2002 trial that was widely misreported; since then, the understanding has shifted considerably, especially around a woman's age and timing when therapy starts.
Read the full answer →Have a question that isn't here? Ask us at your next visit, or ask our AI bone health advisor.
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
